Cipla
Q3 Results | Cipla: Net Profit Rises By 10% To ₹800.96 Cr, Revenue Rises By 5.2%
Wed, Jan 25, 2023
Cipla Ltd on Wednesday reported 9.93 per cent rise in consolidated net profit to ₹800.96 crore for the quarter ended December 2022. Cipla had earned a net profit of Rs 757 crore in the October-December quarter of the last financial year 2021-22. Watch full news in this video.
More >
Cipla Q3 Results: Net profit rises 10% but fails to keep up with analysts' estimates
Wed, Jan 25, 2023
Cipla Q3 Results: The drug maker reported a 9.9 per cent year-on-year increase in net profit to Rs 801 crore for the October-December period and revenue growth of six per cent to Rs 5,810.1 crore — both missing analysts' estimates. Cipla shares extended their intraday losses after the earnings announcement.
More >
After Sensex, Nifty's Santa rally today, these banks and pharma stocks may give returns up to 7-25% - what should investors do?
Mon, Dec 26, 2022
SBI, IndusInd Bank, Cipla may give returns up to 25 per cent on long-term months, say ICICI Securities and Motilal Oswal analysts as Indian shares bounced sharply after last week's bloodbath.
More >
Healthcare stocks Divis Laboratories, Apollo Hospital among others surge up to 7% as fear related to comeback of coronavirus grips
Wed, Dec 21, 2022
To review the Covid preparedness, Union Health Minister Mansukh Mandaviya chaired a meeting with top officials as fresh spurt in cases in countries like Japan, South Korea, Brazil, China, and the US.
More >
Apollo Hospital closes as top gainer for 2nd day, Cipla ends around 1% lower; Analyst expects Nifty all-time high in next day or two
Thu, Nov 24, 2022
Nifty, Sensex, Top Gainers, Top Losers, Apollo Hospital, Infosys, Cipla: According to the market analyst, the rally in the final hour can be attributed to a quick covering move as call writers were trapped.
More >
Correction in Cipla stock, despite 12% consolidated net profit increase in Q2FY23
Mon, Nov 07, 2022
Shares of Cipla Ltd (NSE: CIPLA) corrected in the D street on Nov 7. The downtrend follows despite the third-largest pharma company in India reporting a consolidated net profit increase of 12%.
More >
Cipla Share: Correction in pharma stock despite 12% consolidated net profit increase in Q2
Mon, Nov 07, 2022
Cipla Share Price: Drug major Cipla posted its consolidated net profit of Rs 797 crore, an increase of 12 per cent for the second quarter ended September 30 on the back of robust sales across domestic and the US market.
More >
Pharma stocks in focus: Cipla, Zydus Wellness, Torrent Pharma surge up to 5% after healthy Q1 results – brokerages recommend this
Mon, Aug 01, 2022
Despite healthy Q1FY23 earnings, the pharma major Sun Pharma shares were seen trading flat in the early morning and later declined more than 3 per cent to Rs 913 per share on the BSE intraday on Monday.
More >
Q1 Results FY2023: NTPC, Cipla, Emami, Exide Industries, EIH announce June quarter results - highlights
Fri, Jul 29, 2022
NTPC Q1 Results FY2023: State-owned NTPC on Friday posted a more than 15 per cent increase in consolidated net profit to Rs 3,977.77 crore in the June quarter on the back of higher income
More >
Global View: Hindustan Unilever, Cipla, Infosys and JSW Steel shares can give 12-35% return – know what brokerages say
Mon, Jun 06, 2022
Indian markets on Monday made a gap-down opening as Nifty opened below 16550 levels and Sensex slipped over 100 points. Whereas Nifty Midcap 100 also declined by 0.1 per cent at open.
More >
